• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国南方地区儿童抗 N-甲基-D-天冬氨酸受体脑炎:111 例分析。

Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.

机构信息

Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jin Sui Road, 510623 Guangzhou, Guangdong Province, PR China.

Department of Neurology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, 9# Jin Sui Road, 510623 Guangzhou, Guangdong Province, PR China.

出版信息

J Neuroimmunol. 2021 Mar 15;352:577479. doi: 10.1016/j.jneuroim.2021.577479. Epub 2021 Jan 15.

DOI:10.1016/j.jneuroim.2021.577479
PMID:33486307
Abstract

OBJECTIVE

To study the clinical features of children diagnosed with anti-NMDAR encephalitis in southern China.

METHODS

Clinical data of children diagnosed with anti-NMDAR encephalitis from October 2014 to June 2020 from one national regional medical center were analyzed. Neurological disability was assessed by modified Rankin Scale (mRS) throughout the course of disease.

RESULTS

111 children (M/F = 49/62; mean onset age = 6.8 y) with anti-NMDAR encephalitis were involved. Prodromal events occurred in 34.2% of patients with infectious events being the most common. Seizure was the most common initial symptom, though movement disorder served as the most common event throughout the course of disease. 9.9% of patients had overlapped with other neuronal autoantibodies. Electroencephalogram showed abnormalities with slow wave (100.0%), epileptic discharge (31.5%) and delta brush (8.1%) respectively. 41.4% of patients had abnormal brain MRI, with focal lesions being the most common. None patients had tumor. 80.9% of patients had good response to first line therapy (steroid plus immunoglobulin), while 14 patients accepted second-line therapy (Rituximab) and all had a good response. Boys were significantly more likely to need more course of steroid. 13.8% of patients relapsed. 2 male patients died. mRS score was significantly improved after treatment. 51.4% of patients had a full recovery and 81.7% had mRS score ≤ 2. The median mRS score of boys after treatment was higher than that of girls. Non-infectious prodromal event, past medical history, perivascular lesions in brain MRI, hospital stay, initial mRS score higher than 3, and RTX treatment were independent risk factors associated with poor prognosis, defined as mRS score > 2.

CONCLUSION

Of pediatric anti-NMDAR encephalitis in southern China: median onset age around 7 years; girls more common; boys might have poor outcome than girls; seizure or movement disorder respectively being most common onset or course symptom; a few overlapped with other neuronal autoantibodies; rare combined with tumor; most had a good response to immunotherapy and a good prognosis; relapse rate relatively high; fatality rate relatively low; some risk factors associated with poor prognosis.

摘要

目的

研究中国南方地区抗 NMDAR 脑炎患儿的临床特征。

方法

分析 2014 年 10 月至 2020 年 6 月期间,来自一家国家级区域医疗中心的抗 NMDAR 脑炎患儿的临床资料。采用改良 Rankin 量表(mRS)评估疾病全过程中的神经功能缺损。

结果

共纳入 111 例抗 NMDAR 脑炎患儿(男/女=49/62;平均发病年龄 6.8 岁)。34.2%的患儿有前驱事件,以感染性事件最为常见。癫痫发作是最常见的首发症状,但运动障碍是最常见的疾病过程中的症状。9.9%的患儿与其他神经元自身抗体重叠。脑电图分别表现为慢波(100.0%)、癫痫放电(31.5%)和 δ 刷(8.1%)异常。41.4%的患儿脑 MRI 异常,以局灶性病变最为常见。无患儿存在肿瘤。80.9%的患儿对一线治疗(激素联合免疫球蛋白)反应良好,14 例患儿接受二线治疗(利妥昔单抗),均反应良好。男孩需要更多疗程激素的可能性显著更高。13.8%的患儿复发。2 例男性患儿死亡。治疗后 mRS 评分显著改善。51.4%的患儿完全康复,81.7%的患儿 mRS 评分≤2。治疗后男孩的 mRS 评分中位数高于女孩。非感染性前驱事件、既往病史、脑 MRI 血管周围病变、住院时间、初始 mRS 评分高于 3、RTX 治疗是与预后不良相关的独立危险因素(定义为 mRS 评分>2)。

结论

中国南方地区的儿童抗 NMDAR 脑炎具有以下特点:发病年龄中位数约为 7 岁;女性多见;男孩预后可能较女孩差;癫痫发作或运动障碍分别为最常见的起病或病程症状;少数与其他神经元自身抗体重叠;罕见合并肿瘤;多数患儿对免疫治疗反应良好,预后良好;复发率相对较高;病死率相对较低;存在一些与不良预后相关的危险因素。

相似文献

1
Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases.中国南方地区儿童抗 N-甲基-D-天冬氨酸受体脑炎:111 例分析。
J Neuroimmunol. 2021 Mar 15;352:577479. doi: 10.1016/j.jneuroim.2021.577479. Epub 2021 Jan 15.
2
[Clinical analysis of 71 cases of anti-N-methyl-D-aspartate receptor encephalitis in children].71例儿童抗N-甲基-D-天冬氨酸受体脑炎临床分析
Zhonghua Er Ke Za Zhi. 2019 Feb 2;57(2):125-130. doi: 10.3760/cma.j.issn.0578-1310.2019.02.012.
3
Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.影响抗 N-甲基-D-天冬氨酸受体脑炎患者预后和复发的因素。
Mult Scler Relat Disord. 2023 Jun;74:104697. doi: 10.1016/j.msard.2023.104697. Epub 2023 Apr 3.
4
Clinical characteristics of antiNmethylaspartate receptor encephalitis in children.儿童抗N-甲基-D-天冬氨酸受体脑炎的临床特征
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jan 28;45(1):47-54. doi: 10.11817/j.issn.1672-7347.2020.180761.
5
Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.中国中南地区儿童抗N-甲基-D-天冬氨酸受体脑炎:临床特征、治疗、影响因素及预后
J Neuroimmunol. 2017 Nov 15;312:59-65. doi: 10.1016/j.jneuroim.2017.09.005. Epub 2017 Sep 11.
6
Pediatric anti-NMDAR encephalitis with demyelination on brain MRI: A single center study.儿童抗 NMDAR 脑炎伴脑 MRI 脱髓鞘:单中心研究。
Mult Scler Relat Disord. 2023 Dec;80:105063. doi: 10.1016/j.msard.2023.105063. Epub 2023 Oct 18.
7
Clinical and radiological features, treatment responses and prognosis in pediatric patients with co-existing anti-N-methyl-D-aspartate receptor and myelin oligodendrocyte glycoprotein antibody-associated encephalitis: A single center study.抗 N-甲基-D-天冬氨酸受体和髓鞘少突胶质细胞糖蛋白抗体相关脑炎患儿的临床和影像学特征、治疗反应和预后:一项单中心研究。
Mult Scler Relat Disord. 2024 Jan;81:105133. doi: 10.1016/j.msard.2023.105133. Epub 2023 Nov 13.
8
Brain magnetic resonance imaging as predictors in pediatric anti-N-methyl-D-aspartate receptor encephalitis.脑磁共振成像作为儿科抗 N-甲基-D-天冬氨酸受体脑炎的预测指标。
Mult Scler Relat Disord. 2024 Feb;82:105061. doi: 10.1016/j.msard.2023.105061. Epub 2023 Dec 21.
9
The clinical features, treatment and outcomes of 33 children from Northwestern China with Anti-N-methyl-D-aspartate receptor encephalitis.中国西北部33例抗N-甲基-D-天冬氨酸受体脑炎患儿的临床特征、治疗及预后
Neurol Res. 2022 May;44(5):429-438. doi: 10.1080/01616412.2021.2000824. Epub 2021 Nov 21.
10
Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China.中国抗N-甲基-D-天冬氨酸受体脑炎患者脑电图特征分析
Clin Neurophysiol. 2017 Jul;128(7):1227-1233. doi: 10.1016/j.clinph.2017.04.015. Epub 2017 May 4.

引用本文的文献

1
Risk factors for poor response to initial first-line immunotherapy and subsequent immunotherapy on prognosis in pediatric anti-NMDA receptor encephalitis.小儿抗N-甲基-D-天冬氨酸受体脑炎中初始一线免疫治疗反应不佳及后续免疫治疗对预后的危险因素。
Neurol Sci. 2025 May 16. doi: 10.1007/s10072-025-08210-x.
2
Towards an optimal diagnostic and prognostic model based on semi-quantitative assessment of F-FDG PET in children with autoimmune encephalitis.基于F-FDG PET半定量评估构建儿童自身免疫性脑炎的优化诊断和预后模型
Front Immunol. 2025 Apr 2;16:1457758. doi: 10.3389/fimmu.2025.1457758. eCollection 2025.
3
In Children, -Methyl-D-Aspartate Receptor Antibody Encephalitis Incidence Exceeds That of Japanese Encephalitis in Vietnam.
在越南儿童中,甲基-D-天冬氨酸受体抗体脑炎的发病率超过了日本脑炎。
Open Forum Infect Dis. 2024 Dec 6;11(12):ofae710. doi: 10.1093/ofid/ofae710. eCollection 2024 Dec.
4
The therapeutic effect of ofatumumab in pediatric anti-NMDAR encephalitis: A case series.奥法木单抗治疗儿童抗N-甲基-D-天冬氨酸受体脑炎:病例系列
Heliyon. 2024 Nov 23;10(23):e40680. doi: 10.1016/j.heliyon.2024.e40680. eCollection 2024 Dec 15.
5
Anti--methyl D-aspartate Receptor Encephalitis in India: A Literature Review.印度的抗N-甲基-D-天冬氨酸受体脑炎:文献综述
Ann Indian Acad Neurol. 2023 Jan-Feb;26(1):17-32. doi: 10.4103/aian.aian_519_22. Epub 2023 Jan 25.
6
[Recent research on cytokines associated with anti-N-methyl-D-aspartate receptor encephalitis].[近期关于抗N-甲基-D-天冬氨酸受体脑炎相关细胞因子的研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Mar 15;25(3):321-327. doi: 10.7499/j.issn.1008-8830.2211125.
7
Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis.抗 N-甲基-D-天冬氨酸受体脑炎的免疫治疗研究进展。
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Aug 15;24(8):948-953. doi: 10.7499/j.issn.1008-8830.2204021.
8
External Assessment of the Anti-N-Methyl-D-Aspartate Receptor Encephalitis One-Year Functional Status Score in Chinese Pediatric Patients.中国儿科患者抗 N-甲基-D-天冬氨酸受体脑炎一年功能状态评分的外部评估。
Front Immunol. 2022 Jun 23;13:889394. doi: 10.3389/fimmu.2022.889394. eCollection 2022.
9
Thyroid Function and Anti-thyroid Antibodies in Pediatric Anti-NMDAR Encephalitis.儿童抗NMDAR脑炎中的甲状腺功能及抗甲状腺抗体
Front Neurol. 2021 Sep 9;12:707046. doi: 10.3389/fneur.2021.707046. eCollection 2021.